Telix Educational Webinar: Neuro-Oncology Portfolio Update and Physician Perspectives

Summary

Telix Pharmaceuticals announced an educational webinar to provide a clinical update on unmet needs in neuro-oncology and on its theranostic portfolio for glioma and glioblastoma. The session, featuring neuro-oncology experts from Europe, is positioned to highlight how radiopharmaceutical imaging and therapy may address gaps in brain tumor care ahead of upcoming clinical and regulatory milestones.